Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
Daiichi Sankyo
Moodys
Merck
Argus Health

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 10,064,911

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,064,911
Title:Peptides for treating cancer
Abstract: The present invention relates to peptides for inhibiting angiogenesis. The present invention also relates to methods of inhibiting angiogenesis and methods of treating disorders associated with VEGF-induced vascular permeability using the peptides of the invention.
Inventor(s): Komarova; Yulia A. (Chicago, IL), Rosenblatt; Mark (Chicago, IL), Malik; Asrar B. (Hinsdale, IL)
Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, IL)
Application Number:15/602,096
Patent Claims:see list of patent claims

Details for Patent 10,064,911

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, IL) 2035-03-02 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, IL) 2035-03-02 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, IL) 2035-03-02 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
Covington
UBS
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.